Zurich Cantonal Bank
ADMA icon

Zurich Cantonal Bank’s ADMA Biologics ADMA Stock Holding History

Zurich Cantonal Bank’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$869K Buy
103,815
+4,811
+5% +$43.9K ﹤0.01% 1626
2026
Q1 		$892K Buy
99,004
+20,987
+27% +$331K ﹤0.01% 1496
2025
Q4 		$1.42M Buy
78,017
+6,064
+8% +$102K ﹤0.01% 1139
2025
Q3 		$1.05M Hold
71,953
– – ﹤0.01% 1254
2025
Q2 		$1.31M Buy
71,953
+5,282
+8% +$108K ﹤0.01% 1095
2025
Q1 		$1.32M Buy
66,671
+711
+1% +$12.3K ﹤0.01% 1016
2024
Q4 		$1.13M Buy
65,960
+4,586
+7% +$86.3K ﹤0.01% 1122
2024
Q3 		$1.23M Sell
61,374
-85
-0.1% -$1.32K ﹤0.01% 1026
2024
Q2 		$687K Sell
61,459
-98
-0.2% -$822 ﹤0.01% 1270
2024
Q1 		$406K Buy
61,557
+4,851
+9% +$26.5K ﹤0.01% 1615
2023
Q4 		$256K Buy
56,706
+9,767
+21% +$36.1K ﹤0.01% 1939
2023
Q3 		$168K Buy
46,939
+17,340
+59% +$66.7K ﹤0.01% 2084
2023
Q2 		$109K Sell
29,599
-1,310
-4% -$4.86K ﹤0.01% 2312
2023
Q1 		$102K Sell
30,909
-10,538
-25% -$36.4K ﹤0.01% 2267
2022
Q4 		$161K Buy
41,447
+20,726
+100% +$63.9K ﹤0.01% 1959
2022
Q3 		$50K Hold
20,721
– – ﹤0.01% 2588
2022
Q2 		$41K Sell
20,721
-1,261
-6% -$2.48K ﹤0.01% 2653
2022
Q1 		$40K Buy
+21,982
New +$34.3K ﹤0.01% 2571

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Zurich Cantonal Bank's ADMA Position: Q2 2026 in Review

Zurich Cantonal Bank increased its ADMA Biologics (ADMA) stake by 4.9% in Q2 2026, buying an estimated $43.9K and bringing the position to 103,815 shares worth $869K. The position accounts for ﹤0.01% of the portfolio, ranked #1626.

Zurich Cantonal Bank first reported a position in ADMA in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.42M in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Zurich Cantonal Bank held 103,815 shares of ADMA Biologics worth $869K as of Q2 2026.
  • Zurich Cantonal Bank bought 4,811 ADMA Biologics shares in Q2 2026, an estimated $43.9K.
  • ADMA Biologics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1626 holding.
  • Zurich Cantonal Bank first reported a position in ADMA Biologics in Q1 2022 and has held it in 18 quarters since.
  • Zurich Cantonal Bank's ADMA Biologics position peaked at $1.42M in Q4 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.